Abstract
PC-904 is a new antibiotic agent with a broad spectrum against gram-positive and gram-negative microorganisms.
PC-904, daily dose 2 g, was administered intravenously to 4 cases of pulmonary infectious deseases.
The results were as follows: remarkable effectiveness in 1 case and unknown effectiveness in 3 cases.
Side effects were noted in 2 cases: generalized skin eruptions with elevation of S-GOT and eosinophilia in a suspected pneumonia, and eosinophilia in another one. There disappeared, however, soon after cessation of the administration.
